BioSpace News Archive

Anika Therapeutics, Inc. announced plans to showcase HYALOFAST, a biodegradable, HA-based cartilage repair scaffold, at the 2019 International Cartilage Repair Society (ICRS) Summit.

Sandoz Inc. (Sandoz), a Novartis division, announced the US market introduction of SYMJEPI™ (epinephrine) 0.3 mg Injection for the emergency treatment of allergic reactions (Type 1), including anaphylaxis.

Actelion Pharmaceuticals Ltd announced it has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its supplemental New Drug Application (sNDA) for OPSUMIT® (macitentan) in the treatment of adults with inoperable chronic thromboembolic pulmonary hypertension (CTEPH, WHO Group 4) to improve pulmonary vascular resistance (PVR) and exercise capacity.

Cannabis Growth Opportunity Corporation announced the company has made an investment in Tökr LLC (“tökr”), creators of application software (“app”) that modernizes the cannabis industry by connecting the new cannabis user of today with lifestyle brands that represent quality and reliability.

WebMD celebrated the accomplishments and contributions of researchers, health care professionals and advocates who are helping to transform the impact of cancer during its Health Heroes event in New York City.

Mirati Therapeutics, Inc. announced the pricing of an underwritten public offering of 1,612,903 shares of its common stock at a price to the public of $62.00 per share